Market Movers

China Tower’s Stock Price Skyrockets to 0.98 HKD, Witnessing a Robust Increase of +4.26%

China Tower (788)

0.98 HKD +0.04 (+4.26%) Volume: 537.88M

China Tower’s stock price is currently robust at 0.98 HKD, showcasing a promising +4.26% surge this trading session with a hefty trading volume of 537.88M, and an impressive YTD increase of +18.29%, indicating a solid performance and potential for growth.


Latest developments on China Tower

Key events leading to China Tower’s stock price movements today include a bullish block trade of the company’s shares. An impressive 3.2 million shares were traded at $0.94, resulting in a turnover of $3.008 million. This significant trade through the SH/SZ-HK Stock Connect has undoubtedly influenced the stock price, reflecting the market’s optimistic sentiment towards China Tower (00788).


A look at China Tower Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience2
Momentum5
OVERALL SMART SCORE4.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunication company operating in China, has received high scores in key areas according to Smartkarma Smart Scores. With a perfect score in both Value and Dividend, the company seems to be a solid investment option for those looking for stability and returns. Additionally, a strong score in Momentum indicates positive market sentiment and growth potential for China Tower in the long term.

However, the company received a lower score in Resilience, suggesting potential vulnerabilities in the face of challenges. Despite this, with a solid score in Growth, China Tower shows promise for expansion and development in the future. Overall, the company’s strong performance in key areas bodes well for its long-term outlook in the telecommunications industry in China.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars